Answers are grounded in this paper and cite their sources.
Digital polymerase chain reaction (dPCR) has emerged as an analytically sensitive and precise nucleic acid quantification technology, operating as a third generation of PCR after conventional and real-time quantitative PCR (qPCR). Based on the physical partitioning of a reaction mixture into thousands to millions of independent sub-volumes, dPCR enables absolute quantification using Poisson statistics without external standard curves. This critical narrative review provides a balanced evaluation of dPCR principles, statistical and physical foundations, commercial platforms, and translation into clinical and environmental applications. We performed a structured search of PubMed, Scopus, Web of Science, and ScienceDirect (January 2018 to May 2026), identifying and analyzing 19 representative primary studies. We examine dPCR principles, addressing randomness, molecular linkage, partition occupancy, and thresholding, and the 'rain' phenomenon. Reconstructed platform comparisons evaluate Bio-Rad QX, QIAGEN QIAcuity, and Stilla Naica systems. Clinical validity, utility, and diagnostic sensitivity are critically synthesized across liquid biopsy oncology (including minimal residual disease), non-invasive prenatal testing (NIPT), and infectious disease pathogen diagnosis (specifically SARS-CoV-2 and tuberculosis). Domain-specific subsections examine dPCR for water quality surveillance, food safety, and biotherapy quality control. We discuss analytical, clinical, and implementation limitations, with emphasis on cost, multiplexing, and standardization. Finally, we contextualize dPCR's prospects in the Southeast Asian healthcare setting, where tropical disease burdens create distinct diagnostic opportunities and barriers
No takes yet. Share an insight, caveat, or question.
Phi Nguyen Bang (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: